Serum from 72 patients with cervical cancer treated within a phase III trial with either simultaneous radiochemotherapy ( S-RC ) with cisplatin , or systemic paclitaxel and carboplatin followed by percutaneous radiation ( PC-R ) was analyzed by ELISA .